Targeting mutant estrogen receptors
A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2019-01-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/44181 |